Global Statistics

All countries
554,149,988
Confirmed
Updated on July 3, 2022 2:05 pm
All countries
526,278,889
Recovered
Updated on July 3, 2022 2:05 pm
All countries
6,361,052
Deaths
Updated on July 3, 2022 2:05 pm

Global Statistics

All countries
554,149,988
Confirmed
Updated on July 3, 2022 2:05 pm
All countries
526,278,889
Recovered
Updated on July 3, 2022 2:05 pm
All countries
6,361,052
Deaths
Updated on July 3, 2022 2:05 pm
- Advertisment -

What Is The Survival Rate Of Covid-19

Preliminary Study Providing A Tentative 3% Estimate For Case Fatality Rate

What’s the survival rate for COVID-19 patients on ventilators?

A preliminary study published on The Lancet on January 24 provided an early estimation of 3% for the overall case fatality rate. Below we show an extract :

Of the 41 patients in this cohort, 22 developed severe dyspnoea and 13 required admission to an intensive care unit, and six died.

Hence, the case-fatality proportion in this cohort is approximately 14.6%, and the overall case fatality proportion appears to be closer to 3%.

However, both of these estimates should be treated with great caution because not all patients have concluded their illness and the true number of infections and full disease spectrum are unknown.

Importantly, in emerging viral infection outbreaks the case-fatality ratio is often overestimated in the early stages because case detection is highly biased towards the more severe cases.

As further data on the spectrum of mild or asymptomatic infection becomes available, one case of which was documented by Chan and colleagues, the case-fatality ratio is likely to decrease.

Nevertheless, the 1918 influenza pandemic is estimated to have had a case-fatality ratio of less than 5% but had an enormous impact due to widespread transmission, so there is no room for complacency.

A novel coronavirus outbreak of global health concern – Chen Wang et al., The Lancet. January 24, 2020

Fatality rate can also change as a virus can mutate, according to epidemiologists.

When People Show Their True Colors

These people have not recently lost their way. It is not a matter of disagreeing with the path they’re taking.It’s a matter of human life, and respect for others. I am willing to engage in intelligent discourse with views which differ from my own. But clearly we are past that. We are in the looking glass.I am 55, and prefer to deal in reality. The science has been established. Those who refuse to get vaccinated, without a valid medical reason, are selfish and stupid. They can be nice and wonderful, and a lifelong friend, but the bottom line is, if/when they give me Covid, and I die, their lives will go on, shortly after they spend a few minutes sending their thoughts and prayers.I’m sorry, but I choose my friends wisely, and I thankfully do not have any close friends who subscribe to the MAGA beliefs, or the anti-vax position. I guess I’m lucky in that regard.If I was to meet someone like that, I would not want to become friends with them either. But that’s just me, and everyone has a right to choose who they want to be friends with. Even the poster I responded to. I do not expect her to take the advice of a stranger, like myself, on a message board. And I 100% doubt that they will anyways.

How You Might Feel While Recovering

Not everyone who catches SARS-CoV-2 will notice symptoms. If you do get them, they may show up 2 to 14 days after your infection. And those symptoms can vary from one person to the next.

One of the most common signs is a fever, which for most adults is 100.4 F or higher. It means your body is trying to fight off an invader.

About 50% of people who become ill have a dry cough. Thats the kind that doesnt bring up any mucus or phlegm. But about a third have a cough with mucus.

You also might feel very tired. Less commonly, your throat may be sore and your head might ache. Your muscles and joints could hurt, and you might get chills, nausea, vomiting, or diarrhea.

Some people who had COVID-19 said they had trouble taking deep breaths and felt like they had a tight band wrapped around their chest. Others have likened the illness to a bad cold. Still others said it was the sickest theyve ever felt.

Loss of smell and taste have been reported in many cases. Some patients have skin rashes and darkened toes, called COVID toes.

You might feel short of breath, as if youd just run to grab a ringing phone. If so, call your doctor to ask about what you should do.

Continued

Don’t Miss: Are Canker Sores A Sign Of Covid

Mortality Rate And Characteristics Of Deaths Following Covid

  • 1Department of General Surgery, Chinese PLA General Hospital, Beijing, China
  • 2Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai, China
  • 3Department of Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, United States
  • 4Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center, Memphis, TN, United States

Background: The emergency use authorization for coronavirus disease 2019 vaccines brought both hopes and concerns to the Americans and others. We aimed to estimate the mortality rate of COVID-19 vaccination and presented characteristics of deaths following COVID-19 vaccination.

Methods: Data on deaths following COVID-19 vaccination were obtained from the Vaccine Adverse Event Reporting System from December 11, 2020 through January 8, 2021. The Centers for Disease Control and Prevention COVID Data Tracker was used to identify the total number of people receiving COVID-19 vaccines during the same period to estimate the mortality rate. Stratified analysis was conducted by the location of vaccination.

The benefits of COVID-19 vaccines outweigh the potential risks in older frail populations, and our findings do not support actions to exclude older adults from being vaccinated. However, continued monitoring of COVID-19 vaccination is still warranted.

Degree Of Injury Need For Dialysis

[OC] Mortality Rate of Covid

In total, 139 of 372 patients died. Of the 156 patients with healthy kidneys, 32 died in the hospital, in contrast with 81 of 168 patients with newly developed kidney injury and 11 of 22 with CKD stage 1 through 4.

Among the other 26 patients who had CKD, 9 of 19 patients with end-stage renal failure , who had already required routine outpatient dialysis, died. The death rate was highest in CKD patients who had undergone kidney transplant .

Death rates rose along with worsening kidney injury classified by Kidney Disease: Improving Global Outcomes classification; of 157 patients with stage 0 injury, 33 died, compared with those with more serious stages 1 to 3 injury .

Those who died were more likely to have needed dialysis than survivors . But once dialysis was started, death rates were not significantly different between survivors and non-survivors in patients with new kidney injury or nonend-stage CKD .

Among 216 patients with kidney impairment, 121 needed dialysis in the hospital, and 9 of the 48 survivors who required dialysis for the first time in the ICU continued to need it after they were released, suggesting that COVID-19 may lead to long-term kidney impairment. Most patients II score was 15, with 0 the least likely to die in the ICU and 71 the most likely.

You May Like: Does Covid Make Your Eyes Hurt

How To Calculate The Mortality Rate During An Outbreak

At present, it is tempting to estimate the case fatality rate by dividing the number of known deaths by the number of confirmed cases. The resulting number, however, does not represent the true case fatality rate and might be off by orders of magnitudeA precise estimate of the case fatality rate is therefore impossible at present.

The case fatality rate represents the proportion of cases who eventually die from a disease.

Once an epidemic has ended, it is calculated with the formula: deaths / cases.

But while an epidemic is still ongoing, as it is the case with the current novel coronavirus outbreak, this formula is, at the very least, “naïve” and can be “misleading if, at the time of analysis, the outcome is unknown for a non negligible proportion of patients.”

In other words, current deaths belong to a total case figure of the past, not to the current case figure in which the outcome of a proportion hasn’t yet been determined.

The correct formula, therefore, would appear to be:

CFR = deaths at day.x / cases at day.x-

This would constitute a fair attempt to use values for cases and deaths belonging to the same group of patients.

One issue can be that of determining whether there is enough data to estimate T with any precision, but it is certainly not T = 0 .

Let’s take, for example, the data at the end of February 8, 2020: 813 deaths and 37,552 cases worldwide.

If we use the formula we get:

Comorbidities Appeared To Play A Major Role

Mortality rates were high among hospitalized COVID-19 patients in New York City requiring ventilators, researchers found.

The mortality rate for those who received mechanical ventilation was 24.5%, reported Karina Davidson, PhD, of Feinstein Institutes for Medical Research at Northwell Health in Manhasset, New York, and colleagues, writing in JAMA.

As of April 4, among 1,151 patients requiring mechanical ventilation, 3.3% were discharged alive, 72% remained in the hospital, and the remainder were dead.

Outcomes were assessed for 2,634 COVID-19 patients who died or were discharged from 12 New York City area hospitals . There were 373 patients treated in the intensive care unit , 12.2% receiving invasive mechanical ventilation, and 21% who died.

Of patients who died, the authors found that those with diabetes were more likely to have mechanical ventilation or care in the ICU versus those who did not. Similar findings were seen for patients with hypertension.

The percentage of patients developing acute kidney injury also increased among subgroups with diabetes versus those without diabetes, the authors said. Among patients with outcome data, 3.2% were treated with kidney replacement therapy.

Among patients admitted to the ICU, the median age was 68, and a third were women, the authors said.

Disclosures

Richardson disclosed no conflicts of interest.

Davidson disclosed no conflicts of interest.

Primary Source

JAMA

You May Like: How Do They Test For Covid Antibodies

Mortality Rate Showing Cause Of Death Not On Dashboard

We do not show the mortality rate based on cause of death on the dashboard because we only use data from the recent past, that is, data that we receive per day or week. This data is necessary to follow the epidemic closely and to be able to take timely measures. However, we think it is important to mention the mortality rate based on cause of death, because these are the most accurate figures.

Data From Humanigen’s Phase 3 Covid

Does COVID-19 have a 98 percent survival rate?

Source: Streetwise Reports;;

Clinical-stage biopharmaceutical company Humanigen Inc. , which is focused on developing therapies for treating infectious diseases and cancer, today announced “positive topline results from its Phase 3 clinical trial evaluating the efficacy and safety of lenzilumab in patients hospitalized with COVID-19.”

The firm indicated that at present it is highly focused on the development of lenzilumab for use in the prevention and treatment of an immune hyper-response called cytokine storm, which often can be fatal in SARS-CoV-2 afflicted patients.

The company reported that participants in the Phase 3 study who were given lenzilumab in combination with both steroids and/or remdesivir experienced statistically significant higher survival rates without the need for intermittent mandatory ventilation compared with patients who receiving placebo only together with the other baseline combined treatments.

Andrew Badley, M.D., professor of infectious diseases and professor and chair of the Department of Molecular Medicine at the Mayo Clinic, remarked, “Mayo Clinic is pleased to have been part of the investigation of lenzilumab from the earliest days of the development program in COVID-19 and are excited by these data…If lenzilumab is authorized for emergency use by FDA, and based on our clinical trial experience to date, it may then be considered a part of our treatment armamentarium for newly hospitalized patients with COVID-19.”

Read Also: Where To Get Covid Vaccine Houston

We Dont Know The True Covid

The survival rate for Covid-19 is 98.54% in the UK.

Our verdict

We dont know what the survival rate is yet, as we dont know how many people have had the disease. This figure comes from a claim about the US which is a slight over-estimate based on available figures.

Weve seen a numberposts claiming that the current survival rate for Covid-19 is 98.54% in the UK. These posts have been shared over 14,000 times.

This is wrong. The figure seems to come from a that made the same claim about the US survival rate back in April.;

But we dont yet know the true survival rate there or in the UK, as we dont have a good idea of how many people have had Covid-19. Theres a lot we dont know about the exact death toll either, which weve written more about here.

Fact checkersin the US have reported on the 98.54% claim. It is actually an over-estimate of how many people have had a confirmed case of Covid-19 and have not died at this time. But describing that as the survival rate has problems.

We can calculate this by looking at the case fatality rate, which is the percentage of deaths in patients who had the disease out of the number of confirmed cases. In the US, its currently at roughly 6%, meaning around 94% of those whove had confirmed cases so far have not died. As other fact checkers have pointed out, although a rate of survival around 95% sounds high, this would still make Covid-19 more lethal than seasonal flu.

    Australian Data Answers Key Questions About Covid

    The risk of death after the diagnosis of a COVID-19 infection during Victorias 2020 outbreaks was 4 percent overall but was estimated to be 10 times higher among the elderly, a study from the University of Sydneys NHMRC Clinical trials Centre has found.

    The data analytics study, published in BMC Medical Research Methodology, is a comprehensive assessment of COVID-19 mortality prior to the introduction of vaccines in the state of Victoria, Australia, focusing particularly on the impact of age.

    The findings demonstrate how modelling and data analytics can help answer key questions on COVID-19 infection in an Australian context. This can help guide global surveillance and the development of strategies to forecast and control the pandemic.

    Professor Ian Marschner from the Faculty of Medicine and Health and NHMRC Clinical Trials Centre says the results, particularly the high mortality among the elderly, emphasise the importance of Australias vaccination program.

    He performed the analysis with publiclyavailable COVID-19 surveillance data from Victorias two waves of infection during 2020 .;

    Data from Victoria were used as the Victorian health department publishes comprehensive data on age, and the Victorian outbreak comprised the majority of Australian cases in 2020.;

    Although it is well known that older age is a key risk factor for COVID-19 death, there are many related questions for which we have not had good answers, he said.

    Read Also: How Does Covid Symptoms Start

    Outcome Subgroup Analysis And Statistical

    Our only outcome of interest was hospital mortality. We conducted 2 subgroup analyses restricted to studies with same characteristics population and a low risk of bias: critical illness subgroup analysis ; general patients admitted to hospital subgroup analysis .

    The bias level was estimated using the Cochrane Collaboration risk-of-bias instrument .

    Singlearm metaanalysis were performed using the statistical software package meta in R and for a 5% significance level. Random-effect models were estimated using inverse variance method. Logit transformation was performed on the data and continuity correction of 0.5 was applied in studies were zero frequencies were observed. Heterogeneity among studies was tested using 2 statistics and I2 statistics. Funnel plot was used to detect the publication bias . Models were estimated considering all studies, and according with general patients admitted to hospital, critical illness, and severe population .

    The Op Is Wrong You Don’t Get The Vaccine After Case Confirmation

    The benefits of getting the COVID
    Read my post.The 2% figure DOES NOT APPLY because it based on the 1.6% figure that applies to CONFIRMED CASES.Get a positive test and you have a 1.6% chance of dying.That’s not a population statistic. The number of people in the stadium is a population statistic, in the analogy.You don’t get the vaccination after a case confirmation.If you are comparing the rate of death in the total population, to compare apples to apples and populations to analogy, then you have to use the 0.2% figure.

    Read Also: Is Covid 19 A Natural Disaster

    Days From First Symptom To Death

    The Wang et al. February 7 study published on JAMA found that the median time from first symptom to dyspnea was 5.0 days, to hospital admission was 7.0 days, and to ARDS was 8.0 days.

    Previously. the China National Health Commission reported the details of the first 17 deaths up to 24 pm 22 Jan 2020. A study of these cases found that the median days from first symptom to death were 14 days, and tended to be shorter among people of 70 year old or above than those with ages below 70 year old (20 days.

    Median Hospital Stay

    The JANA study found that, among those discharged alive, the median hospital stay was 10 days.

    This Startup Raised $100 Million To Turbocharge Womens Health

    For the overall non-institutionalized population in Indiana, the IFR came out to be 0.26 percent. In other words, for every 1000 people in the community who had gotten infected, an estimated 2.6 ended up dying. The average age at death was 76.9 years.

    The calculated IFR increased with age. It was 0.01 percent for those 12 to 40 years old, 0.12 percent for those 40 to 59 years old, and 1.71 percent for those 60 years and older. Men had a higher IFR than women .

    You may have heard that pandemic has been hitting non-Whites worse than Whites. Well, surprise, surprise, non-Whites had an IFR of over three times that of Whites . Before you blame age for this difference, consider this result: the average age of death for non-Whites was 73.3 years old compared to 78.9. So non-Whites were dying not only more frequently but also on average at a younger age.

    The World Health Organization has reported an infection fatality rate of 0.5 to 1 … percent for the Covid-19 coronavirus,

    So, what does this all mean? The overall IFR from this Indiana study was a little lower than the 0.5 to 1 percent range reported by the World Health Organization , based on other studies. Undoubtedly, people will begin twisting these new numbers like a fishing net made out of Twizzlers to fit their political and business agendas. Therefore, its really important to keep in mind what the limitations of this study are and what you can and cant get from the IFR.

    You May Like: Does Your Nose Burn With Covid

    - Advertisment -

    Hot Topics

    - Advertisment -

    Related Articles